Literature DB >> 3257732

Differential effects of 1 alpha,25-dihydroxycholecalciferol and 24R,25-dihydroxycholecalciferol on the proliferation and the differentiated phenotype of rabbit costal chondrocytes in culture.

M Takigawa1, M Enomoto, E Shirai, Y Nishii, F Suzuki.   

Abstract

1 alpha,25-Dihydroxycholecalciferol [1,25-(OH)2D3] stimulated the proliferation and DNA synthesis of rabbit costal growth cartilage cells in the logarithmic growth phase in culture. The stimulatory effects of 1,25-(OH)2D3 were observable at a concentration of 10(-10) M and maximal at a concentration of 10(-8) M. On the other hand, 1,25-(OH)2D3 inhibited their expression of the cartilage phenotype, as judged morphologically, histochemically, and biochemically by a decrease in glycosaminoglycan (GAG) synthesis. The inhibition of GAG synthesis was also dose dependent and observable at a concentration of 10(-10) M. 1,25-(OH)2D3 also stimulated the proliferation of resting cartilage cells and inhibited their GAG synthesis, but its effects on these cells were less than those on growth cartilage cells, suggesting that 1,25-(OH)2D3 acts more specifically on growth cartilage cells than on resting cartilage cells. 1,25-(OH)2D3 had no effect on either DNA synthesis or GAG synthesis of growth cartilage cells in confluent cultures. 24R,25-Dihydroxycholecalciferol [24,25-(OH)2D3] had no effect on proliferation, DNA synthesis, or GAG synthesis of growth cartilage cells in the logarithmic growth phase. However, 24,25-(OH)2D3 had no effect on DNA synthesis of these cells in confluent cultures, but stimulated their expression of the cartilage phenotype. The stimulatory effect was dose dependent and maximal at 10(-7) M. Since chondrocytes express their differentiated phenotype as they become confluent in culture, these results suggest that 1,25-(OH)2D3 stimulates the growth of rapidly proliferating chondrocytes with a poorly differentiated phenotype and suppresses their expression of the cartilage phenotype, while 24,25-(OH)2D3 stimulates expression of the differentiated phenotype of highly differentiated chondrocytes.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3257732     DOI: 10.1210/endo-122-3-831

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  7 in total

1.  1,25(OH)2D3 receptor regulation and 1,25(OH)2D3 effects in primary cultures of growth cartilage cells of the rat.

Authors:  G Klaus; J Merke; H Eing; U Hügel; P Milde; H Reichel; E Ritz; O Mehls
Journal:  Calcif Tissue Int       Date:  1991-11       Impact factor: 4.333

2.  Role of 1,25-dihydroxycholecalciferol in growth-plate cartilage: inhibition of terminal differentiation of chondrocytes in vitro and in vivo.

Authors:  Y Kato; A Shimazu; M Iwamoto; K Nakashima; T Koike; F Suzuki; Y Nishii; K Sato
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

3.  Vitamin D metabolites prevent vertebral osteopenia in ovariectomized rats.

Authors:  R G Erben; H Weiser; F Sinowatz; W A Rambeck; H Zucker
Journal:  Calcif Tissue Int       Date:  1992-03       Impact factor: 4.333

4.  Selective expression of a normal action of the 1,25-dihydroxyvitamin D3 receptor in human skin fibroblasts with hereditary severe defects in multiple actions of that receptor.

Authors:  J Barsony; W McKoy; D A DeGrange; U A Liberman; S J Marx
Journal:  J Clin Invest       Date:  1989-06       Impact factor: 14.808

5.  Effect of vitamin D on growth cartilage cell proliferation in vitro.

Authors:  G Klaus; R Meinhold-Heerlein; P Milde; E Ritz; O Mehls
Journal:  Pediatr Nephrol       Date:  1991-07       Impact factor: 3.714

6.  1,25-Dihydroxyvitamin D3 and 22-oxa-1,25-dihydroxyvitamin D3 in vivo nuclear receptor binding in developing bone during endochondral and intramembranous ossification.

Authors:  W E Stumpf; N Koike; N Hayakawa; K Tokuda; K Nishimiya; Y Tsuchiya; J Hirate; A Okazaki; K Kumaki
Journal:  Histochemistry       Date:  1994-09

7.  Proto-oncogene expression in a human chondrosarcoma cell line: HCS-2/8.

Authors:  J D Zhu; H O Pan; F Suzuki; M Takigawa
Journal:  Jpn J Cancer Res       Date:  1994-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.